Related Experiment Video
Updated: Aug 19, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Hepatitis C: prevalence and common genotypes among ethnic groups in Jeddah, Saudi Arabia
Insights
Hepatitis C virus (HCV) antibody prevalence was 6.75% overall in Jeddah, Saudi Arabia. Egyptians had the highest HCV infection rate (22.54%), with genotype 4 being predominant in both Egyptians and Saudis.
Area of Science:
- Virology
- Epidemiology
- Public Health
Background:
- Hepatitis C virus (HCV) poses a significant global health challenge.
- Understanding HCV prevalence and genotypes is crucial for effective control strategies.
- Previous data on HCV epidemiology in Saudi Arabia and surrounding regions were limited.
Purpose of the Study:
- To determine the prevalence of antibodies to Hepatitis C virus (HCV) in a diverse patient population in Jeddah, Saudi Arabia.
- To identify the distribution of different HCV genotypes within the studied population.
- To compare HCV prevalence across different nationalities and patient groups.
Main Methods:
- A cross-sectional study was conducted involving 3,350 serum samples.
- Samples were collected from outpatient clinics, preoperative patients, and antenatal care attendees between January and September 1998.
- Third-generation ELISA was used for antibody detection, and genotyping was performed on positive samples.
Main Results:
- The overall prevalence of HCV antibodies was 6.75%.
- Prevalence varied significantly by nationality: Egyptians (22.54%), Saudis (5.87%), Yemenis (2.12%), and other Middle Eastern/Asian countries (3.38%-4.98%).
- In Saudi Arabia, HCV genotype 4 (45.9%) and 1a (40.6%) were most common. In Egypt, genotype 4 was highly prevalent (91.6%).
Conclusions:
- HCV infection represents a considerable public health issue in Jeddah, with notable variations in prevalence among different nationalities.
- Genotype 4 is the predominant HCV type among Egyptians and a significant type among Saudis in this region.
- Targeted screening and intervention strategies may be necessary, considering the high prevalence in specific ethnic groups like Egyptians.
Abstract:
The presence of antibodies to hepatitis C virus (HCV) was examined using a third-generation ELISA in 3,350 serum samples obtained from patients visiting different outpatient clinics, preoperative patients, and women visiting for ante-natal care at the Dr. Fakeeh hospital in Jeddah, Saudi Arabia from January to September 1998. The population included mainly Saudis, Egyptians, and Yemenis, and patients from other Middle East and Asian countries. The prevalence of HCV infection was 5.87% among Saudis, 22.54% among Egyptians, and 2.12% among Yemenis. The prevalence among patients from other Middle East and Asian countries were 3.38% and 4.98%, respectively. The overall prevalence among the studied group was 6.75%. Genotyping of isolates from Saudi Arabia showed that the prevalences of types 4, la, 1b, and 2 were 45.9%, 40.6%, 10.85%, and 2.7%, respectively. Genotyping of isolates from Egypt showed that type 4 was the major type among Egyptians (91.6%), while types 1a and 1b each had prevalences of 4.2%.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Hepatitis
Viral Hepatitis I: Introduction

